Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Expert Opinion on Pharmacotherapy
|
March 5, 2004
A subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer
Ramon Perez-Marrero, Robert C Tyler
Biochemistry
|
January 6, 2010
Distal interactions within the par3-VE-cadherin complex
Robert C Tyler, Francis C Peterson, Brian F Volkman
Journal of the American Society for Mass Spectrometry
|
April 8, 2011
Dynamic interchanging native states of lymphotactin examined by SNAPP-MS
Qingyu Sun, Robert C Tyler, Brian F Volkman, et al.
Biochemistry
|
October 30, 2012
Electrostatic optimization of the conformational energy landscape in a metamorphic protein
Robert C Tyler, Jamie C Wieting, Francis C Peterson, et al.
Biochemistry
|
July 23, 2011
Native-state interconversion of a metamorphic protein requires global unfolding
Robert C Tyler, Nathan J Murray, Francis C Peterson, et al.
Biochemistry
|
August 20, 2010
Backbone amide dynamics studies of Apo-L75F-TrpR, a temperature-sensitive mutant of the tryptophan repressor protein (TrpR): comparison with the (15)N NMR relaxation profiles of wild-type and A77V mutant Apo-TrpR repressors
Anupam Goel, Brian P Tripet, Robert C Tyler, et al.
Journal of Molecular Biology
|
November 18, 2005
Solution structure of isoform 1 of Roadblock/LC7, a light chain in the dynein complex
Jikui Song, Robert C Tyler, Min S Lee, et al.
The Journal of Urology
|
August 21, 2002
A clinical study of 22.5 mg. La-2550: A new subcutaneous depot delivery system for leuprolide acetate for the treatment of prostate cancer
Franklin M Chu, Maury Jayson, Martin K Dineen, et al.
Protein Science : a Publication of the Protein Society
|
July 28, 2005
Three-dimensional structure of the AAH26994.1 protein from Mus musculus, a putative eukaryotic Urm1
Shanteri Singh, Marco Tonelli, Robert C Tyler, et al.
Clinical Therapeutics
|
December 28, 2002
A six-month, open-label study assessing a new formulation of leuprolide 7.5 mg for suppression of testosterone in patients with prostate cancer
Ramon Perez-Marreno, Franklin M Chu, Donald Gleason, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Expert Opinion on Pharmacotherapy
|
March 5, 2004
A subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer
Ramon Perez-Marrero, Robert C Tyler
Biochemistry
|
January 6, 2010
Distal interactions within the par3-VE-cadherin complex
Robert C Tyler, Francis C Peterson, Brian F Volkman
Journal of the American Society for Mass Spectrometry
|
April 8, 2011
Dynamic interchanging native states of lymphotactin examined by SNAPP-MS
Qingyu Sun, Robert C Tyler, Brian F Volkman, et al.
Biochemistry
|
October 30, 2012
Electrostatic optimization of the conformational energy landscape in a metamorphic protein
Robert C Tyler, Jamie C Wieting, Francis C Peterson, et al.
Biochemistry
|
July 23, 2011
Native-state interconversion of a metamorphic protein requires global unfolding
Robert C Tyler, Nathan J Murray, Francis C Peterson, et al.
Biochemistry
|
August 20, 2010
Backbone amide dynamics studies of Apo-L75F-TrpR, a temperature-sensitive mutant of the tryptophan repressor protein (TrpR): comparison with the (15)N NMR relaxation profiles of wild-type and A77V mutant Apo-TrpR repressors
Anupam Goel, Brian P Tripet, Robert C Tyler, et al.
Journal of Molecular Biology
|
November 18, 2005
Solution structure of isoform 1 of Roadblock/LC7, a light chain in the dynein complex
Jikui Song, Robert C Tyler, Min S Lee, et al.
The Journal of Urology
|
August 21, 2002
A clinical study of 22.5 mg. La-2550: A new subcutaneous depot delivery system for leuprolide acetate for the treatment of prostate cancer
Franklin M Chu, Maury Jayson, Martin K Dineen, et al.
Protein Science : a Publication of the Protein Society
|
July 28, 2005
Three-dimensional structure of the AAH26994.1 protein from Mus musculus, a putative eukaryotic Urm1
Shanteri Singh, Marco Tonelli, Robert C Tyler, et al.
Clinical Therapeutics
|
December 28, 2002
A six-month, open-label study assessing a new formulation of leuprolide 7.5 mg for suppression of testosterone in patients with prostate cancer
Ramon Perez-Marreno, Franklin M Chu, Donald Gleason, et al.
Page
of 3